키드위즈 로고

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

WAYNE, BloodVitals wearable PA (February 24, 2016) - LifeScan, Inc. has introduced the brand new OneTouch Verio Flex™ blood glucose monitoring system, at-home blood monitoring with ColorSure™ know-how - a easy, BloodVitals test correct and easy-to-use meter that takes the guesswork out of understanding blood sugar check outcomes for wireless blood oxygen check folks with diabetes. Its simple colour range indicator makes use of color to immediately inform patients when their blood glucose readings are "low," "in range," or "high" to allow them to rapidly get on with their lives. Nine out of 10 individuals with diabetes agreed that the meter’s colour vary indicator helped them simply interpret their blood sugar readings. While it has broad enchantment as a easy, intuitive meter by itself, patients may also use the meter’s constructed-in Bluetooth® Smart Technology to wirelessly join with the companion OneTouch Reveal® mobile app obtainable on compatible iOS and BloodVitals SPO2 Android cell units. "Research shows that ease of use stays an important motive for meter selection by a majority of patients while, at the identical time, one third say they can’t make sense of their blood sugar outcomes," said Dr. Jeremy Pettus, Endocrinologist and BloodVitals SPO2 Assistant Professor of Medicine at the University of California, San Diego.

"The new OneTouch Verio Flex™ meter is designed to assist individuals with diabetes higher understand and manage their blood glucose. The low and excessive vary limits set in the OneTouch Verio Flex™ meter will be customized for each affected person based on their healthcare professional’s suggestions. With every test, the straightforward colour range indicator shows whether or not a result's below limit (blue), within range (inexperienced) or above the limit (purple). Nine out of 10 healthcare professionals agreed that understanding when their readings are in or out of range could assist patients attain their blood sugar targets and stay in higher control. Currently, there are an estimated 29 million people with diabetes within the US and plenty of don’t BloodVitals test their blood sugar repeatedly or as really helpful by their healthcare skilled. Seven out of 10 individuals with diabetes agreed that the OneTouch Verio Flex™ meter with its simple color range indicator might encourage them to check as really useful.

The OneTouch Verio®IQ meter that spots patterns and helps patients understand how insulin, meals and lifestyle have an effect on their numbers. LifeScan has begun delivery the brand new OneTouch Verio Flex™ system to retailers and it will soon be out there nationally wherever diabetes testing supplies are offered with an estimated retail value of $19.99. OneTouch® is probably the most really useful model by endocrinologists and primary care physicians. LifeScan, Inc. is a part of the Johnson & Johnson Diabetes Care Companies. With a shared vision of creating a world with out limits for folks with diabetes, the Johnson & Johnson Diabetes Care Companies is a collaboration of Johnson & Johnson firms dedicated to diabetes and consists of LifeScan, Inc., a world leader in blood glucose monitoring; Animas Corporation, maker of progressive insulin delivery programs; and Calibra Medical, Inc., developer of a unique 3-day wearable insulin patch pump. Within the US, LifeScan, Inc. is the main maker of blood glucose monitoring programs and its OneTouch® model merchandise are beneficial by more endocrinologists and major care physicians than every other brand.

Globally, more than 10 million people depend upon OneTouch® brand merchandise for simple testing and correct results to assist them manage their diabetes. This press release contains "forward-trying statements" as defined within the Private Securities Litigation Reform Act of 1995 relating to the new OneTouch Verio Flex™ blood glucose monitoring system. The reader is cautioned not to depend on these ahead-wanting statements. These statements are based mostly on present expectations of future occasions. If underlying assumptions show inaccurate or known or unknown dangers or uncertainties materialize, actual outcomes could fluctuate materially from the expectations and projections of LifeScan, Inc. and/or Johnson & Johnson. Risks and uncertainties embody, however will not be limited to: uncertainty of business success; challenges to patents; competition, including technological advances, new products and patents attained by opponents; modifications to relevant legal guidelines and regulations, including global well being care reforms; changes in habits and spending patterns or monetary distress of purchasers of well being care services; product efficacy or safety concerns leading to product recalls or regulatory action; manufacturing difficulties and delays; and developments toward well being care price containment.